CURRICULUM VITAE

Somchai Laowattana, MD, PhD

**** * ******* **, ********, WI 53132

Email: ac87yy@r.postjobfree.com

BOARD CERTIFICATIONS:

**** ********* #***** – Board Certification in Neurology

1999Diplomate #1090 – Board Certification in Clinical Neurophysiology

1998Diplomate #45599 – Board Certification in Neurology

OTHER CERTIFICATIONS:

2009, 1995, 1993 Advanced Cardiac Life Support and Basic Life Support

1993-permanent FLEX Part 1&2, Score 85/88 percentile

1992-permanent ECFMG Part 1&2 Score, 83/84 percentile

LANGUAGES:

English, Thai, Spanish, and Mandarin Chinese

EDUCATIONS:

May 1980 – March 1986 Suankularb High School

Bangkok, Thailand

June 1986 – March 1992 Chulalongkorn University Medical School

Bangkok, Thailand

POSTDOCTORIAL TRAININGS:

July 1999 – May 2004 Doctoral Program (PhD) in Clinical Investigation

Johns Hopkins University School of Medicine and School of Hygiene and Public Health

Baltimore, MD

July 1998 – June 1999 Fellowship in Cerebrovascular Disease

Department of Neurology

Johns Hopkins Medical Institutions

Baltimore, MD

July 1997 – June 1998 Fellowship in Neurophysiology and Epilepsy

Department of Neurology

Yale University School of Medicine/ Yale-New Haven Hospital

New Haven, CT

July 1994 – June 1997 Residency in Neurology

Department of Neurology

Vanderbilt University Medical Center

Nashville, TN

July 1993 – June 1994 Internship in Internal Medicine

Department of Internal Medicine

University of Connecticut Health Science Center

Farmington, CT

ACADEMIC AND ADMINISTRATIVE APPOINTMENTS:

January 2017 – Present Neurologist

Medical College of Wisconsin/Froedtert Hospital

Milwaukee, WI

June 2009 – January 2017 Neurologist

Lakeshore-Aurora Medical Group

Milwaukee, WI

July 2005 - May 2009 Assistant Professor

Department of Neurology

Baylor College of Medicine

Houston, TX

January 2004 – June 2005 Assistant Professor

Department of Neurology

Virginia Commonwealth University

Richmond, VA

August 2001 – December 2003 Assistant Professor

Department of Neurology

George Washington University

Washington, DC

July 2002 – December 2003 Sponsorship Committee

American Heart Association

Annandale, VA

July 2002 – December 2003 Writing Committee and Central Stroke Adjudicator

Women Health Initiatives

National Institute of Health

Bethesda, MD

July 1999 – July 2001 Instructor

Department of Neurology

Johns Hopkins University School of Medicine

Baltimore, MD

MEMBERSHIPS-SCIENTIFIC, HONORARY & PROFESSIONAL SOCIETIES:

1996-Active Member – American Academy of Neurology

1992-Active Member – Thailand Physician Society

SPECIAL AWARDS, FELLOWSHIPS, AND OTHER HONORS:

2017-Present “Who’s Who in the World’s Lifetime Achievement Award”

2009-Present “Who’s Who in America”, 64th Edition, 2010, Marquis Who’s Who in America,

America’s leading biographical reference publisher since 1899.

1992 1st Class Honor in the graduation from the medical school

1992 Highest score in the FMGEMS Examination for the Class of Med Chula 42

1988 An award for the top score in Neuroscience and Behavioral Science

Chulalongkorn University Medical School

1986 Highest score in The Prestigious King’s Scholarship Examination

1986 King’s Scholarship Award, Bangkok, Thailand

1986 Highest score in The National University Examination among 3000,000 examinees

1986 Award for Most Distinguished Student for Scholarship of Suankularb College

1984 Honored Certificate of Excellence from the Minister of Education,

Dr. Kamol Thongthammachat

1983 Honored Certificate of Excellence from the Prime Minister Professor Thanin Kaiwichian

1981-1986 Five successive years of Scholarship for Excellent Academic Achievement from

Mr. Lek Samuttarapraput, a former Distinguished Teacher of Suankularb College

1980 Highest score in Bangkok Metropolitan High School Examination

RESEARCH:

2010-Present Principal Investigator

“Brain mechanism of mindfulness meditation”

2009 Co-Investigator

“Depression in epilepsy patients”

2008 Principal Investigator

“Congential carotid hypoplasia in ischemic stroke”

2007 Principal Investigator

“Protective effects of beta-blockers in cerebrovascular disease”

Sponsoring Institution: National Institute of Health (NIH)

2005 Principal Investigator

“Left insular stroke is associated with adverse cardiac outcome”

Sponsoring Institution: National Institute of Health (NIH)

2003 Principal Investigator

“Dose escalation study of desmoteplase in acute ischemic stroke” (DEDAS)

Sponsoring Institution: Paion Pharmaceutical Co., Ltd., Germany

2003 Principal Investigator

“Rapid response with an astrocyte modulator in acute cortical stroke” (RREACT)

Sponsoring Institution: ONO Pharmaceutical Co., Ltd., Japan

2002-2003 Principal Investigator

“Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischemic attack or ischemic stroke” (MATCH)

Sponsoring Institution: Sanofi-Synthelabo Co., Ltd.

2002-2003 Co-Investigator

Women Health Initiatives

Sponsoring Institution: National Institute of Health (NIH)

1998-2001Co-Investigator

“Cardiac autonomic consequence of hemispheric stroke”

Sponsoring Institution: National Institute of Health (NIH)

Doctoral Thesis:

Left insular stroke and the risk of adverse cardiac outcome

Thesis Advisor: Scott Zeger, PhD, Professor and Chairman,

Department of Biostatistics, Johns Hopkins University

School of Public Health

Thesis Committee: Joao Lima, MD, Steve Goodman, MD, PhD

and Ilan Wittstein, MD., Johns Hopkins Medical Institutions.

Invited CME Lectures and Courses:

CME lecture: Epilepsy case studies

Fall Conference 2009, Aurora Health Care, Milwaukee, WI

December 12, 2009

CME lecture: Acute management and secondary prevention for ischemic stroke

Boone Clinic, Norfolk, VA

May 11, 2005

Bon Secours Memorial Regional Medical Center, Mechanicsville, VA

May 17, 2005

Grand round lecture: Left insular stroke, adverse cardiac outcome, neurogenic stunned

Myocardium

Department of Neurology, University of Texas Medical Branch, Galveston, TX

May 31, 2005

CME symposium: Advances in stroke: prevention, treatment and research (Chair, Speaker)

Virginia Commonwealth University, November 13, 2004

CME lecture: Current therapy for ischemic stroke

Charley’s Waterfront Café, Farmville, VA

October 12, 2004

Dinner lecture: Inflammation and vascular disease: what is the state of evidence?

2941 Restaurant, Falls Church, VA

July 28, 2004

Dinner lecture: Secondary prevention of Stroke

Galileo Restaurant, Washington DC

August 20, 2003

CME course : Prevention and acute treatment of stroke (Chair, Speaker)

George Washington University

March 11, 2003

Community lecture: Stroke prevention

George Washington University Hospital

November 6, 2002

Internal Medicine Grand Round: Adverse cardiac outcome after left insular stroke

Department of Internal Medicine, George Washington University,

May 30, 2002

Increased sympathetic tone, measured by high 24 hour urine VMA, interacts with coexisting heart disease to cause adverse cardiac outcome among stroke survivors

Department of Neurology, University of Pennsylvania,

October 16, 2001

Department of Neurology, University of Illinois

November 9, 2001

Publications:

1Friedman DE, Kung DH, Laowattana S, Kass JS, Hrachovy R, Levin HS. Identifying depression in a busy clinical setting is enhanced with systematic screening. Seizure: the journal of the British Epilepsy Association 2009:18(6);429-433.

2 Sachdev N, Laowattana S, Belorgey LB, Thaver GH. Congential carotid hypoplasia in ischemic

stroke. Neurology 2008;70(22):2086.

3Laowattana S, Oppenheimer SM. Protective effects of beta-blockers in cerebrovascular disease. Neurology 2007;68:509-514. (Highlighted Article).

4Laowattana S, Zeger SL, Lima JAC, Goodman SM, Wittstein IS, Oppenheimer SM. Left insular stroke is associated with adverse cardiac outcome. Neurology 2006;66:477-483 (Highlighted Article, CME Article, and Editorial Comments on the Article).

5Sen S, Laowattana S, Lima J, Oppenheimer S. Risk factors for intra-cardiac thrombus in patients with recent ischemic cerebrovascular events. JNNP 2004; 75:1421-1425.

6Smoller S, Hendrix S, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb D, Black H, Rossouw J, Aragaki A, Safford M, Stein E, Laowattana S, Mysiw J: For the WHI Investigators. Effect of estrogen plus progestin on stroke in the Women’s Health Initiatives. JAMA 2003; 289 (20):2673-718.

7Laowattana S, Abou-Khalil B, Fakhoury T, Meade D. Brief antiepileptic withdrawal prolongs interval to next seizure. Neurology 1999;53(8):1736-41.

Book Publications

1Laowattana S. “Left insular stroke and cardiac outcome”. 2009. Publisher: VDM Verlag Dr.

Muller. World-wide distribution.

2Laowattana S. “Maths for Entrance": A textbook for students taking The National University

Examination offering a "short cut" to solve mathematics problems.

Abstracts and National Meeting Presentations

1 Laowattana S, Kent T, Oppenheimer, SM. Potential Mechanisms for Protective Effects of β-

Blockers in Acute Stroke Patients. Stroke 2006; 37: 661. The International Stroke Conference

2006, February 2006, Kissimmee, FL.

2 Laowattana S, Oppenheimer SM. Prevalence and Outcome for Stroke/TIA Patients with

Asymptomatic Coronary Artery Disease. Stroke 2006; 37: 702. The International Stroke

Conference 2006, February 2006, Kissimmee, FL.

3 Laowattana S, Lima J, Zeger S, Goodman S, Wittstein I, Oppenheimer S. Left insular stroke is

associated with adverse cardiac outcome. Stroke 2005;36:440. The International Stroke

Conference 2005, February 2005, New Orleans, LA, and the 57th Annual Meeting of the

American Academy of Neurology, April 2005, Miami Beach, FL.

4 Laowattana S, Lima J, Zeger S, Goodman S, Wittstein I, Oppenheimer S. Left insular stroke is

associated with neurogenic stunned myocardium with ischemic preconditioning phenomenon.

Stroke 2005;36:440-441. The International Stroke Conference 2005, February 2005, New

Orleans, LA, and the 57th Annual Meeting of the American Academy of Neurology, April

2005, Miami Beach, FL.

5Laowattana S, Oppenheimer S. Use of β-blocker is associated with less severe stroke upon

presentation. Neurology Today 2005 (March): 86-88, Stroke 2005;36:489. The International

Stroke Conference 2005, February 2005, New Orleans, LA, the 2nd International Conference

on Women, Heart, Disease, and Stroke, February 2005, Orlando, FL, and the 57th Annual

Meeting of the American Academy of Neurology, April 2005, Miami Beach, FL

6Laowattana S, Lima J, Zeger S, Goodman S, Wittstein I, Oppenheimer S. Positive results of hypercoagulable workup are associated with asymptomatic coronary artery disease among stroke/TIA patients. The 2nd International Conference on Women, Heart, Disease, and Stroke, February 2005, Orlando, FL,

7 Laowattana S, Lima J, Zeger S, Goodman S, Wittstein I, Oppenheimer S. Sympatholytic medications, not ACEI or calcium channel blockers, protect against adverse cardiac outcome from left insular stroke. Neurology 2004;62(7, suppl 5):A241-A242. The 56th American Academy of Neurology Meeting, April 2004, San Francisco, CA.

8 Laowattana S, Lima J, Zeger S, Goodman S, Wittstein I, Oppenheimer S. Left insular stroke increases risk of adverse cardiac outcome through impairment of cardiac parasympathetic tone. Neurology 2003;60(5, suppl 1):A520-521. The 55th American Academy of Neurology Meeting, March 2003, Honolulu, HI.

9 Laowattana S, Lima J, Zeger S, Goodman S, Wittstein I, Oppenheimer S. Increased risk of cardiovascular outcomes and neurogenic stunned myocardium in patients with stroke localized in the left insula. Circulation 2001;104 (17, suppl):II- 531. The American Heart Association Meeting, November 2001, Anaheim, CA.

10 Laowattana S, Oppenheimer S. High 24-hour urine VMA is a predictor of sudden cardiac death and adverse cardiac utcomes among stroke patients, not among TIA patients. Neurology 2000;54 (7, suppl 3):A454-A455. The 52nd American Academy of Neurology Meeting, April 2000, San Diego, CA.

11 Laowattana S, Wityk R, Rashba S, Oppenheimer S. Stroke, not TIA, causes late potentials on high resolution EKG recording. Neurology 1999;52(6, Suppl 2):A150. The 51st American Academy of Neurology Annual Meeting, April 1999, Toronto, Canada.

12 Laowattana S, Wityk R, Rashba S, Oppenheimer S. Stroke, not TIA, causes neurogenic stunned myocardium which may be associated with late potentials. Neurology 1999;52 (6, suppl 2):A302-A303. The 51st American Academy of Neurology Annual Meeting, April 1999, Toronto, Canada.

13 Laowattana S, Abou-Khalil B, Fakhoury T. A prospective study of seizure frequency following withdrawal and reinstitution of the antiepileptic drugs. Epilepsia 1996;37 (suppl 5):175. The 50th American Epilepsy Society Meeting, December 1996, San Francisco, California.

14 Pina-Garza EJ, Bukhari AA, Laowattana S, Stalmasel V, Wittgren M, Abou-Khalil B, McLean MJ. Treatment of patients with refractory partial epilepsies with gabapentin: a retrospective analysis. Epilepsia 1995; 36 (suppl 4):69. The 49th American Epilepsy Society Meeting, December 1995, Baltimore, Maryland.

Contact this candidate